PATENT CLAIM ANALYSIS

Application Number: 15885462
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["514", "253040"]

Abstract:
The present invention relates to stable liquid formulations of ketoprofen, amitriptyline, and oxymetazoline.

Claim (Index 29):
A liquid pharmaceutical formulation comprising 0.1-1.0 g/L ketoprofen, 0.05-0.5 g/L amitriptyline, 0.05-0.5 g/L oxymetazoline, about 0.002-1.0% (w/v) Na 2 EDTA, and 10-500 mM Na citrate, in a medium comprising 10-70% (v/v) PEG 400 and 30-90% v/v water, with a pH of 5.0-6.2, wherein the ketoprofen, amitriptyline, and oxymetazoline are soluble, and wherein the ketoprofen, amitriptyline, oxymetazoline are stable for at least six months when stored at a temperature of between 2\u00b0 C. and 30\u00b0 C.

Metadata:
- Claim Count in Document: 83.0
- Percentile: 86.0
- Lexical Diversity: 1.06667
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13047386', '10138192', '12384781', '14721151', '14061039']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7519637873934144
- 35 USC 102 Novelty (BERT): 0.5197080709371206
- Combined Prediction Score: 0.7287382157477851
- Mean Citation Score: 282.707414
- Max Citation Score: 305.0422700000001
- Similarity Product: 194.0113314579476

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test